We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
188 hedge funds and large institutions have $4.11B invested in Acadia Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 67 increasing their positions, 67 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
30% more capital invested
Capital invested by funds: $3.17B → $4.11B (+$939M)
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
14% more call options, than puts
Call options by funds: $36.7M | Put options by funds: $32.2M
0% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 67
3% less funds holding
Funds holding: 193 → 188 (-5)
17% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 30
Holders
188
Holders Change
-5
Holders Change %
-2.59%
% of All Funds
5.07%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
25
Increased
67
Reduced
67
Closed
30
Calls
$36.7M
Puts
$32.2M
Net Calls
+$4.49M
Net Calls Change
-$9.09M
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$33.3M |
| 2 |
VAM
Visium Asset Management
New York
|
+$32.4M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
+$27.5M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$22.6M |
| 5 |
Millennium Management
New York
|
+$20.8M |
